Clinical Trials Logo

Cancer clinical trials

View clinical trials related to Cancer.

Filter by:

NCT ID: NCT03391115 Completed - Cancer Clinical Trials

Personalized Experiences to Inform Improved Communication for Minorities With Life Limiting Illness

Start date: November 15, 2017
Phase:
Study type: Observational

The purpose of this research is to develop patient-centered palliative care interventions to improve patient-provider communication and Quality of Life (QoL) of ethnic and racial minority patients living with life-limiting illnesses. Eliciting personal experiences is an effective way for patients to communicate their cultural values and beliefs. This study will assess how to integrate the patients' personal experience narratives into the electronic health record (EHR). The primary hypothesis is that the implementation of a patient-centered intervention to elicit personal experiences that are included in the EHR will improve patient-provider communication and patients' QoL.

NCT ID: NCT03387891 Completed - Cancer Clinical Trials

Clinical Testing of the Cortrium C3 Device

Start date: May 3, 2017
Phase:
Study type: Observational

Clinical data validation of the C3 device as a Vital Sign Monitoring System for patients under cancer treatment.

NCT ID: NCT03386383 Completed - Cancer Clinical Trials

mHealth Physical Activity Intervention for Survivors of Adolescent and Young Adult Cancers

THRIVE
Start date: February 28, 2018
Phase: N/A
Study type: Interventional

The purpose of this study is to examine the feasibility, acceptability, and gather preliminary data on outcomes of a 3-month mHealth intervention to promote physical activity among adolescent and young adult (AYA) cancer survivors compared to a delayed intervention control group.

NCT ID: NCT03382171 Completed - Cancer Clinical Trials

The Impact of a Home Delivered Meal Service in Cancer Patients During Chemotherapy

Start date: November 17, 2017
Phase: N/A
Study type: Interventional

Cancer patients receiving treatment such as chemotherapy experience a variety of symptoms that interfere with their appetite and their ability to eat and enjoy meals. Therefore, adapting meals in a way that responds to these symptoms might be a good strategy to improve patient satisfaction, nutritional status and hence, quality of life. In this vein, the investigators hypothesize that meals from FoodforCare at Home will contribute to the quality of life of cancer patients undergoing chemotherapy when compared to usual care.

NCT ID: NCT03375086 Completed - Cancer Clinical Trials

A Study of APX3330 in Patients With Advanced Solid Tumors

APX3330
Start date: January 30, 2018
Phase: Phase 1
Study type: Interventional

This is a Phase 1, multi-center, open-label, dose-escalation oncology study of APX3330 in patients with advanced solid tumors.

NCT ID: NCT03371147 Completed - Cancer Clinical Trials

CancerLife: Patient-Driven Solution in Cancer Care

Start date: March 15, 2018
Phase: N/A
Study type: Interventional

The primary purpose of this study is to evaluate the use of a digital information and communication platform (DICP) in improving outcomes in patients with cancer and their caregivers.

NCT ID: NCT03367767 Completed - Cancer Clinical Trials

Age-Related Eye Disease Study 2 (AREDS2) 10-year Follow-On

Start date: May 23, 2018
Phase:
Study type: Observational

Background: Age-related macular degeneration (AMD) and cataracts are two eye diseases. They were studied in the Age-Related Eye Disease Study (AREDS2) and the AREDS2 Follow-On study. These studies followed the natural course of the diseases. They also provided data on the long-term effects of certain oral supplements on AMD. Objective: To study the long-term effects of oral supplements on several things. These include incidences of lung cancer, development of late AMD, cataract surgery, cognitive function, and cardiovascular events. Eligibility: Former AREDS2 and AREDS2 Follow-On participants Design: Participants will have 1 visit. It will include: An eye exam that tests how well participants can see, measures eye pressure, and checks eye movements. The pupil will be dilated with eye drops. Pictures will be taken of the retina and the inside of the eye. Participants will grip a device in their hand to measure their grip strength. A blood sample will be taken. This will be stored for future genetic research. Cells may be created from the sample. A small sample of skin will be taken. Sponsoring Institution: National Eye Institute

NCT ID: NCT03360695 Completed - Breast Cancer Clinical Trials

Bridge: Proactive Psychiatry Consultation and Case Management for Patients With Cancer

Start date: December 11, 2017
Phase: N/A
Study type: Interventional

The purpose of this research is to understand if it is helpful for patients with mental illness to be connected to a psychiatrist and case manager at the time of cancer diagnosis.

NCT ID: NCT03357861 Completed - Cancer Clinical Trials

Cancer Patients Treated With Immunotherapy in Intensive Care Unit

IMMUNO-REA
Start date: September 1, 2018
Phase:
Study type: Observational

This work aims to describe the characteristics and methods of management of patients suffering from a solid tumor treated with immunotherapy admitted to intensive care.

NCT ID: NCT03352934 Completed - Cancer Clinical Trials

Avelumab Treatment in Patients With Neuroendocrine Carcinomas (NEC G3) Progressive After Chemotherapy

AveNEC
Start date: December 7, 2017
Phase: Phase 2
Study type: Interventional

The purpose of the AveNEC trial is to investigate the clinical activity and safety of avelumab in patients with NEC G3 (WHO 2010), including "NET G3" who are progressive after first line chemotherapy.